[go: up one dir, main page]

WO1992001794A3 - Proteines semblables a l'ancrod, leur fabrication et utilisation - Google Patents

Proteines semblables a l'ancrod, leur fabrication et utilisation Download PDF

Info

Publication number
WO1992001794A3
WO1992001794A3 PCT/EP1991/001361 EP9101361W WO9201794A3 WO 1992001794 A3 WO1992001794 A3 WO 1992001794A3 EP 9101361 W EP9101361 W EP 9101361W WO 9201794 A3 WO9201794 A3 WO 9201794A3
Authority
WO
WIPO (PCT)
Prior art keywords
ancrod
proteins
preparation
amino
glycosylated
Prior art date
Application number
PCT/EP1991/001361
Other languages
German (de)
English (en)
Other versions
WO1992001794A2 (fr
Inventor
Alfred Bach
Heinz Hillen
Siegfried Bialojan
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Priority to JP91512191A priority Critical patent/JPH05508771A/ja
Priority to DE59106997T priority patent/DE59106997D1/de
Priority to CA002083286A priority patent/CA2083286C/fr
Priority to EP91912909A priority patent/EP0540560B1/fr
Publication of WO1992001794A2 publication Critical patent/WO1992001794A2/fr
Publication of WO1992001794A3 publication Critical patent/WO1992001794A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

On décrit des polypeptides glycosylés, partiellement glycosylés ou non glycosylés avec les séquences d'acides aminés indiquées dans le protocole de séquence, dans lesquels jusqu'à 10 radicaux d'acide aminé peuvent être échangés contre les radicaux d'autres acides aminés naturels. Ces peptides conviennent à la lutte contre les maladies.
PCT/EP1991/001361 1990-07-26 1991-07-19 Proteines semblables a l'ancrod, leur fabrication et utilisation WO1992001794A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP91512191A JPH05508771A (ja) 1990-07-26 1991-07-19 Ａｎｃｒｏｄ類似蛋白質、その製造及び使用
DE59106997T DE59106997D1 (de) 1990-07-26 1991-07-19 Ancrod ähnliche proteine, ihre herstellung und verwendung.
CA002083286A CA2083286C (fr) 1990-07-26 1991-07-19 Fibrinogenogenases recombinants, leur preparation et leur utilisation
EP91912909A EP0540560B1 (fr) 1990-07-26 1991-07-19 Proteines semblables a l'ancrod, leur fabrication et utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4023699.4 1990-07-26
DE4023699A DE4023699A1 (de) 1990-07-26 1990-07-26 Neue proteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
WO1992001794A2 WO1992001794A2 (fr) 1992-02-06
WO1992001794A3 true WO1992001794A3 (fr) 1992-03-05

Family

ID=6411021

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1991/001361 WO1992001794A2 (fr) 1990-07-26 1991-07-19 Proteines semblables a l'ancrod, leur fabrication et utilisation

Country Status (8)

Country Link
EP (1) EP0540560B1 (fr)
JP (1) JPH05508771A (fr)
AT (1) ATE130872T1 (fr)
CA (1) CA2083286C (fr)
DE (2) DE4023699A1 (fr)
DK (1) DK0540560T3 (fr)
ES (1) ES2080326T3 (fr)
WO (1) WO1992001794A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3841736A1 (de) * 1988-12-10 1990-07-05 Basf Ag Ancrod-proteine, ihre herstellung und verwendung
KR0127776B1 (ko) * 1994-10-11 1997-12-29 허영섭 신규한 단백질 분해효소의 cDNA 서열 및 그로 부터 유래된 단백질
US5955306A (en) * 1996-09-17 1999-09-21 Millenium Pharmaceuticals, Inc. Genes encoding proteins that interact with the tub protein

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585653A (en) * 1984-02-27 1986-04-29 Robert L. Letcher Neuraminidase treated ancrod
US4610879A (en) * 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
WO1990006362A1 (fr) * 1988-12-10 1990-06-14 Basf Aktiengesellschaft Proteines d'ancrod, leur production et utilisation
EP0395375A1 (fr) * 1989-04-26 1990-10-31 Knoll Ag Séquence d'ADN codant pour des polypeptides assimilables à l'ancrod et compositions comprenant les produits d'expression de celles-ci

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610879A (en) * 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
US4585653A (en) * 1984-02-27 1986-04-29 Robert L. Letcher Neuraminidase treated ancrod
WO1990006362A1 (fr) * 1988-12-10 1990-06-14 Basf Aktiengesellschaft Proteines d'ancrod, leur production et utilisation
EP0395375A1 (fr) * 1989-04-26 1990-10-31 Knoll Ag Séquence d'ADN codant pour des polypeptides assimilables à l'ancrod et compositions comprenant les produits d'expression de celles-ci

Also Published As

Publication number Publication date
ES2080326T3 (es) 1996-02-01
DE59106997D1 (de) 1996-01-11
WO1992001794A2 (fr) 1992-02-06
DE4023699A1 (de) 1992-01-30
CA2083286C (fr) 2001-11-27
CA2083286A1 (fr) 1992-01-27
EP0540560A1 (fr) 1993-05-12
EP0540560B1 (fr) 1995-11-29
JPH05508771A (ja) 1993-12-09
ATE130872T1 (de) 1995-12-15
DK0540560T3 (da) 1995-12-27

Similar Documents

Publication Publication Date Title
CA2155185A1 (fr) Reactifs par affinite, totalement synthetiques
EP2145897A3 (fr) Procédés thérapeutiques et compositions basées sur des protéines serrate et acides nucléiques
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
WO1989009787A3 (fr) Dispositifs osteogeniques
CA2263889A1 (fr) Proteines ligands de p-selectine
CA2094027A1 (fr) Peptides osteogenes
CA2042016A1 (fr) Peptides et polypeptides recombinants, acides nucleiques codant pour ceux-ci et utilisation de ces peptides et polypeptides dans le diagnostic de la tuberculose
CA2287521A1 (fr) Beta-interferon recombinant humain ayant une meilleure solubilite
GR3033328T3 (en) Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis.
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
NO992158L (no) Nukleinsyre- og aminosyresekvenser forbundet med Heliobacter Pylori og vaksinepreparater av disse.
CA2316447A1 (fr) Mutants rantes et leurs applications therapeutiques
EP0250000A3 (en) Polypeptides, their preparation and their use
WO1992001794A3 (fr) Proteines semblables a l'ancrod, leur fabrication et utilisation
CA2056467A1 (fr) Somatotrophines presentant des alterations dans la region 1 de l'alpha-helice, et combinaisons avec d'autres mutations
AU5407190A (en) Peptides having novel polar n-terminal groups
AU6406590A (en) Porcine lactoferrin amino acid and cdna sequence
CA2163805A1 (fr) Nouveau facteur d'activation des leucocytes
CA2004764A1 (fr) Proteines ancrod, leur preparation et leur utilisation
EP0311228A3 (fr) Polypeptides recombinants et leur utilisation, y compris un diagnostic pour le virus du SIDA
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
IE890719L (en) Modified proteins
EP0317279A3 (fr) Peptides pour l'usage dans la purification du facteur-VIII
CA2247998A1 (fr) Fragments de recepteur du complement de type 1 et leurs utilisations
ITMI912837A0 (it) Procedimento per preparare prodotti peptidici e/o proteinici arricchiti con amminoacidi legati in modo covalente

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1991912909

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2083286

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1991912909

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991912909

Country of ref document: EP